Is CME's EPS growth sustainable beyond 2025?

**CME's EPS growth appears sustainable beyond 2025**, based on several key factors: 1. **Consistent Financial Performance**: CME has demonstrated strong financial performance in recent years, with a 10% revenue increase in 2024 and record-breaking quarterly revenues. The company's net income grew by 9% in 2024, indicating a robust profitability trend. 2. **Strategic Growth Initiatives**: CME has outlined strategic priorities for 2025, focusing on international growth, product innovation, and new customer acquisition. These initiatives are likely to contribute to sustained growth in the coming years. 3. **Technological Advancements**: The company's partnership with Google Cloud to explore tokenization and other innovative solutions could lead to new revenue streams and efficiency gains, supporting long-term growth. 4. **Dividend History and Yield**: CME has a history of returning value to shareholders, with a dividend yield that has been competitive with the 10-year Treasury in recent years. The company's consistent dividend payments suggest a strong commitment to shareholder returns and financial stability. 5. **Market Position and Product Offerings**: As the world's leading derivatives marketplace, CME offers a diverse range of products across major asset classes. The company's ability to innovate and adapt to market needs, as evidenced by new product launches and partnerships, positions it well for sustained growth. 6. **Institutional Confidence**: Institutional investors have shown confidence in CME, with strong investor demand and strategic partnerships. This confidence is reflected in the company's market capitalization and consistent earnings growth. Overall, while there is always uncertainty in financial forecasting, the combination of CME's strong financial performance, strategic initiatives, and technological advancements suggest that the company's EPS growth could be sustainable beyond 2025.